LoneStar Heart, Inc. Featured in Emerging Company Profile in BioCentury Magazine.
The announcement follows a study conducted by researchers at the University of Texas Southwestern Medical Center (UT Southwestern), published in the on-line May 13th issue of the journal Nature, demonstrating feasibility of the approach. The company has acquired exclusive worldwide rights to the new technology.
Data from LoneStar Heart’s first-in-man study has recently been published in Cell Transplantation. Free full text for Lee et. al. “Polymer-based restoration of left ventricular mechanics” is available here.
To learn more about Texans for Stem Cell Research, check their website at http://www.txstemcell.org/
LoneStar Heart Acquires Worldwide Exclusive Rights to New Class of Small Molecules That May Lead to New Treatments for Diabetes
LoneStar Heart Inc. Names Andrew J. Coats, M.D., and Mark Maciejewski to its Board of Directors